These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 591614

  • 1. The placental transfer of propylthiouracil, methimazole and carbimazole.
    Marchant B, Brownlie BE, Hart DM, Horton PW, Alexander WD.
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
    [Abstract] [Full Text] [Related]

  • 2. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
    Lazarus JH, Marchant B, Alexander WD, Clark DH.
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
    [Abstract] [Full Text] [Related]

  • 3. Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.
    Taurog A, Dorris ML.
    Endocrinology; 1988 Feb; 122(2):592-601. PubMed ID: 3338414
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T, Taurog A, Riesco G.
    Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
    [Abstract] [Full Text] [Related]

  • 5. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
    Lees JF, Alexander WD.
    Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
    [Abstract] [Full Text] [Related]

  • 6. Methimazole and propylthiouracil equally cross the perfused human term placental lobule.
    Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3099-102. PubMed ID: 9284751
    [Abstract] [Full Text] [Related]

  • 7. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL, Olsen J, Wu CS, Laurberg P.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [Abstract] [Full Text] [Related]

  • 8. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
    Motonaga K, Ota M, Odawara K, Saito S, Welsch F.
    Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
    [Abstract] [Full Text] [Related]

  • 9. Excretion of methimazole in human milk.
    Johansen K, Andersen AN, Kampmann JP, Mølholm Hansen JM, Mortensen HB.
    Eur J Clin Pharmacol; 1982 Oct; 23(4):339-41. PubMed ID: 6897386
    [Abstract] [Full Text] [Related]

  • 10. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N, Noh JY, Ishikawa N, Ito K.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A, Taurog A, Engler H, Dorris ML.
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of 35S-labelled antithyroid drugs in man.
    Alexander WD, Evans V, MacAulay A, Gallagher TF, Londono J.
    Br Med J; 1969 May 03; 2(5652):290-1. PubMed ID: 4180995
    [Abstract] [Full Text] [Related]

  • 13. [The effects of propylthiouracil on the fetal thyroid and serum concentration in pregnant women].
    Feng Q, Gao Y, Li H.
    Zhonghua Nei Ke Za Zhi; 1996 May 03; 35(5):295-8. PubMed ID: 9387610
    [Abstract] [Full Text] [Related]

  • 14. Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.
    Papapetrou PD, Marchant B, Gavras H, Alexander WD.
    Biochem Pharmacol; 1972 Feb 01; 21(3):363-77. PubMed ID: 4111354
    [No Abstract] [Full Text] [Related]

  • 15. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE.
    J Clin Endocrinol Metab; 1984 May 01; 58(5):868-72. PubMed ID: 6200492
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of developmental toxicity of propylthiouracil and methimazole.
    Mallela MK, Strobl M, Poulsen RR, Wendler CC, Booth CJ, Rivkees SA.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Aug 01; 101(4):300-7. PubMed ID: 24980470
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of antithyroid drugs.
    Benker G, Reinwein D.
    Klin Wochenschr; 1982 Jun 01; 60(11):531-9. PubMed ID: 6180218
    [No Abstract] [Full Text] [Related]

  • 18. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A, Kung J.
    Expert Opin Drug Saf; 2014 Oct 01; 13(10):1397-406. PubMed ID: 25156887
    [Abstract] [Full Text] [Related]

  • 19. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun 01; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 20. Effects of developmental hypothyroidism induced by maternal administration of methimazole or propylthiouracil on the immune system of rats.
    Nakamura R, Teshima R, Hachisuka A, Sato Y, Takagi K, Nakamura R, Woo GH, Shibutani M, Sawada J.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1630-8. PubMed ID: 17996672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.